Intimation of Schedule of Analyst / Investors Meet is submitted.

Ref: AHCL/2026-27/C036 August 25, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No C/1, “G” Block, Dalal Street, Bandra-Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 SCRIP Code: 544350 Symbol: AGARWALEYE Dear Sir / Madam, Sub: Schedule of Analyst / Investors Meet Ref: Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the captioned subject and reference, we wish to inform you that the Officials of the Company will be participating in the following Investor Conferences / Meetings: Date of Conference / Mode of Type of Organised by Location Meeting Meeting Meeting Group & September 16, 2026 Jefferies India Forum Physical Gurgaon One-on-one Group & September 17 - 18, 2026 Kotak Healthcare Forum Physical Mumbai One-on-one In line with our Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information, no unpublished price-sensitive information or forward-looking statements will be disclosed or discussed during the aforesaid Analyst / Investor meetings & conferences. Please note that changes may happen to the above-mentioned schedule owing to exigencies on part of the Analyst / Investors / Company. We request you to kindly take the above on record. For Dr. Agarwal’s Health Care Limited Thanikainathan Arumugam Company Secretary and Compliance Officer